![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Siegfried Ltd Zofingen Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Dextropropoxyphene hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1996-068 - Rev 03
This Chemical Type CEP, issued on May 21, 2007, remains in force until November 10, 2009, ensuring its reliability within the pharmaceutical industry.
Substance Number 713 associated with this CEP further emphasizes